Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cogstate Ltd ( (AU:CGS) ) has provided an update.
Cogstate Ltd has provided an updated notification to the ASX regarding its ongoing on-market share buy-back of ordinary fully paid shares under the code CGS. The company reported that it had repurchased a cumulative total of 744,799 shares prior to the previous trading day and a further 107,707 shares on the previous day, reflecting continued capital management activity that reduces the number of shares on issue.
The latest update, dated 23 March 2026, follows the original buy-back notification lodged on 11 November 2025 and a prior update on 19 March 2026. Regular daily disclosures of buy-back volumes signal Cogstate’s adherence to ASX reporting requirements and provide investors with transparency on the scale and pace of the program, which can influence earnings per share and shareholder value over time.
The most recent analyst rating on (AU:CGS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Cogstate Ltd stock, see the AU:CGS Stock Forecast page.
More about Cogstate Ltd
Cogstate Ltd is an Australian-listed company trading under the ASX code CGS, with ordinary fully paid shares on issue. The company operates in the cognitive science and technology sector, providing digital cognitive assessment tools and related services, primarily to healthcare, clinical trial, and research markets.
YTD Price Performance: -4.42%
Average Trading Volume: 194,669
Technical Sentiment Signal: Buy
Current Market Cap: A$370.6M
See more insights into CGS stock on TipRanks’ Stock Analysis page.